Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Mequitazine

🥰Excellent
Catalog No. T4499Cas No. 29216-28-2
Alias Virginan, Primalan, Metaplexan, LM-209

Mequitazine (Virginan) is an effective, nonsedative and long-acting histamine H1 antagonist.

Mequitazine

Mequitazine

🥰Excellent
Purity: 99.98%
Catalog No. T4499Alias Virginan, Primalan, Metaplexan, LM-209Cas No. 29216-28-2
Mequitazine (Virginan) is an effective, nonsedative and long-acting histamine H1 antagonist.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
5 mg$42In StockIn Stock
10 mg$58In StockIn Stock
25 mg$91In StockIn Stock
50 mg$124In StockIn Stock
100 mg$156In Stock-
1 mL x 10 mM (in DMSO)$46In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.98%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Mequitazine (Virginan) is an effective, nonsedative and long-acting histamine H1 antagonist.
In vitro
Mequitazine is widely studied and used for allergic disorders such as hay fever and urticaria[1]. Mequitazine demonstrates significant bactericidal effects against all the tested clinical isolates including Ps. aeruginosa. Its effect against the Gram-positive isolates is more pronounced [2].
In vivo
Mequitazine antagonizes the effect of histamine in guinea-pig ileum competitively. Mequitazine at 107 produces a parallel shift of the dose-response curve to acetylcholine in the rat duodenum. Mequitazine at highest concentration shows anticholinergic activity [3]. Mequitazine inhibits contractile responses to KCl, phenylephrine (PE), 5-hydroxytryptamine (5-HT), and Ca2+ in rat aorta [4].
SynonymsVirginan, Primalan, Metaplexan, LM-209
Chemical Properties
Molecular Weight322.47
FormulaC20H22N2S
Cas No.29216-28-2
SmilesC(C1CN2CCC1CC2)N1c2ccccc2Sc2ccccc12
Relative Density.1.28 g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 50 mg/mL (155.05 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween-80+45% Saline: 2.5 mg/mL (7.75 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.1011 mL15.5053 mL31.0106 mL155.0532 mL
5 mM0.6202 mL3.1011 mL6.2021 mL31.0106 mL
10 mM0.3101 mL1.5505 mL3.1011 mL15.5053 mL
20 mM0.1551 mL0.7753 mL1.5505 mL7.7527 mL
50 mM0.0620 mL0.3101 mL0.6202 mL3.1011 mL
100 mM0.0310 mL0.1551 mL0.3101 mL1.5505 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Mequitazine | purchase Mequitazine | Mequitazine cost | order Mequitazine | Mequitazine chemical structure | Mequitazine in vivo | Mequitazine in vitro | Mequitazine formula | Mequitazine molecular weight